Novo Nordisk ADR [NVO] stock prices are up 1.52% to $59.63 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The NVO shares have gain 7.23% over the last week, with a monthly amount glided 6.22%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Novo Nordisk ADR [NYSE: NVO] stock has seen the most recent analyst activity on October 01, 2025, when HSBC Securities upgraded its rating to a Buy. Previously, Morgan Stanley downgraded its rating to Underweight on September 29, 2025, and kept the price target unchanged to $47. On September 17, 2025, upgrade upgraded it’s rating to Buy. Rothschild & Co Redburn upgraded its rating to a Buy. Bernstein upgraded its rating to a Outperform. BNP Paribas Exane upgraded its rating to Neutral for this stock on August 13, 2025, but kept the price target unchanged to $54. In a note dated August 05, 2025, UBS downgraded an Neutral rating on this stock.
The stock price of Novo Nordisk ADR [NVO] has been fluctuating between $45.05 and $120.56 over the past year. Currently, Wall Street analysts expect the stock to reach $55 within the next 12 months. Novo Nordisk ADR [NYSE: NVO] shares were valued at $59.63 at the most recent close of the market. An investor can expect a potential drop of -7.76% based on the average NVO price forecast.
Analyzing the NVO fundamentals
The Novo Nordisk ADR [NYSE:NVO] reported sales of 45.45B for trailing twelve months, representing a surge of 18.96%. Gross Profit Margin for this corporation currently stands at 0.84% with Operating Profit Margin at 0.46%, Pretax Profit Margin comes in at 0.45%, and Net Profit Margin reading is 0.36%. To continue investigating profitability, this company’s Return on Assets is posted at 0.23, Equity is 0.78 and Total Capital is 0.52. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.59.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 58.69 points at the first support level, and at 57.74 for the second support level. However, for the 1st resistance point, the stock is sitting at 60.33, and for the 2nd resistance point, it is at 61.04.
Ratios To Look Out For
It’s worth pointing out that Novo Nordisk ADR [NYSE:NVO]’s Current Ratio is 0.78. Also, the Quick Ratio is 0.56, while the Cash Ratio stands at 0.09. Considering the valuation of this stock, the price to sales ratio is 4.42, the price to book ratio is 10.01 and price to earnings (TTM) ratio is 16.43.
Transactions by insiders
Recent insider trading involved Novo Nordisk A/S, 10% Owner, that happened on May 30 ’25 when 0.92 million shares were purchased.
